Journal article

Manganese chelation therapy extends survival in a mouse model of M1000 prion disease

Marcus W Brazier, Irene Volitakis, Magda Kvasnicka, Anthony R White, John R Underwood, Jason E Green, Sen Han, Andrew F Hill, Colin L Masters, Steven J Collins

Journal of Neurochemistry | WILEY | Published : 2010


Awarded by National Health and Medical Research Council (NHMRC)

Awarded by Grants-in-Aid for Scientific Research

Funding Acknowledgements

The authors thank the Animal Housing Facility staff in the Faculty of Medicine, Dentistry and Health Sciences, the University of Melbourne for their assistance with animal husbandry.SJ Collins, AR White, AF Hill and CL Masters receive support from a National Health and Medical Research Council (NHMRC) Program Grant # 400202. SJ Collins is a recipient of an NHMRC Practitioner Fellowship # 400183. AF Hill is the recipient of an NHMRC RD Wright Career Development Award. The Australian National CJD Registry is funded by the Commonwealth Department of Health and Ageing. The anti-prion protein monoclonal antibody ICSM18 was a generous gift from Professor John Collinge.